Ron Bentsur
2011 - Keryx Biopharmaceuticals
In 2011, Ron Bentsur earned a total compensation of $887.4K as Chief Executive Officer at Keryx Biopharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,338 |
|---|---|
| Option Awards | $262,590 |
| Salary | $300,000 |
| Stock Awards | $114,500 |
| Total | $887,428 |
Bentsur received $300K in salary, accounting for 34% of the total pay in 2011.
Bentsur also received $210.3K in non-equity incentive plan, $262.6K in option awards and $114.5K in stock awards.
Rankings
In 2011, Ron Bentsur's compensation ranked 6,094th out of 10,747 executives tracked by ExecPay. In other words, Bentsur earned more than 43.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,094 out of 10,747 | 43rd |
Division Manufacturing | 2,206 out of 3,960 | 44th |
Major group Chemicals And Allied Products | 498 out of 1,038 | 52nd |
Industry group Drugs | 324 out of 786 | 59th |
Industry Pharmaceutical Preparations | 258 out of 571 | 55th |
Source: SEC filing on October 10, 2014.
Bentsur's colleagues
We found one more compensation record of an executive who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2011.
2011
James Oliviero
Keryx Biopharmaceuticals